Commentary on and reprint of EPIC (Evaluation of 7E3 for the Prevention of Ischemic Complications) Investigators, The, Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty, in New England Journal of Medicine (1994) 330:956–961
Year: 2000
Type: editorial
Source: Elsevier eBooks
Parent work: Hematology
Authors: M LICHTMAN, J SPIVAK, L BOXER, S SHATTIL, E HENDERSON
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2493925730
